Testing dialysis adequacy and patient outcomes
Part of Hormones & metabolism clinical trials.
This study measures how well a dialysis method called haemodiafiltration removes waste products from the blood, tracks how patients feel, and monitors sodium balance. It aims to improve treatment for people with kidney failure on dialysis.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You need to be able to understand and agree to participate.
- You must have end-stage kidney disease and been on haemodialysis for at least 3 months.
- Your doctor estimates you have a life expectancy of more than 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares a newer type of dialysis called hemodiafiltration with standard hemodialysis to see if it improves certain health measures in people with end-stage kidney disease. It may help determine which method works better for long-term treatment.
This trial tests if adjusting the salt (sodium) in your dialysis fluid can improve your health. It is for people on dialysis who have trouble with too much fluid gain or high blood pressure between sessions.
This study looks at how different types of dialysis affect salt stored in your tissues and your small blood vessels. It may help doctors understand how to improve dialysis treatments.
This trial compares two types of dialysis (hemodiafiltration and standard hemodialysis) to see which works better for older adults with kidney failure. You may be eligible if you are over 84, have been on dialysis for at least 3 months, and are generally healthy enough to participate.
This trial tests whether adding a special filter called pHA130 to your regular dialysis treatments can better remove certain waste products from your blood and improve your quality of life. It's for people who have been on dialysis for at least 3 months and meet a few health requirements.
This trial tests whether adding a special blood-filtering device (hemoadsorption) to your regular dialysis treatment can reduce uncomfortable symptoms caused by kidney failure, like fatigue or itching. Researchers will track how you feel over time compared to standard dialysis alone.
Hear when a new Haemodialysis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.